Steve N. Slilaty
2021
In 2021, Steve N. Slilaty earned a total compensation of $462.4K as Chief Executive Officer and Director at Sunshine Biopharma.
Compensation breakdown
| Salary | $156,380 |
|---|---|
| Stock Awards | $306,000 |
| Total | $462,380 |
Slilaty received $306K in stock awards, accounting for 66% of the total pay in 2021.
Slilaty also received $156.4K in salary.
Rankings
In 2021, Steve N. Slilaty's compensation ranked 10,879th out of 12,406 executives tracked by ExecPay. In other words, Slilaty earned more than 12.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,879 out of 12,406 | 12th |
Division Manufacturing | 4,788 out of 5,492 | 13th |
Major group Chemicals And Allied Products | 2,148 out of 2,368 | 9th |
Industry group Drugs | 1,910 out of 2,089 | 9th |
Industry Pharmaceutical Preparations | 1,411 out of 1,536 | 8th |
Source: SEC filing on October 18, 2023.
Slilaty's colleagues
We found two more compensation records of executives who worked with Steve N. Slilaty at Sunshine Biopharma in 2021.